Reference
Kim BJ, et al. EFFICACY AND SAFETY OF SINGLE-PILL COMBINATION OF OLOMAXA (OLMESARTAN, AMLODIPINE, AND ROSUVASTATIN) IN HYPERTENSIVE PATIENTS WITH LOW-TOMODERATE CARDIOVASCULAR RISK. Journal of Hypertension 41 (Suppl. 1): e324, Jan 2023 [abstract]
Rights and permissions
About this article
Cite this article
Amlodipine/olmesartan-medoxomil/rosuvastatin. Reactions Weekly 1945, 44 (2023). https://doi.org/10.1007/s40278-023-34125-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-34125-x